Viewing Study NCT05462756


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-02-05 @ 6:38 PM
Study NCT ID: NCT05462756
Status: COMPLETED
Last Update Posted: 2025-04-27
First Post: 2022-07-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections
Sponsor: Eli Lilly and Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-08-11
Start Date Type: ACTUAL
Primary Completion Date: 2024-02-27
Primary Completion Date Type: ACTUAL
Completion Date: 2024-02-27
Completion Date Type: ACTUAL
First Submit Date: 2022-07-14
First Submit QC Date: None
Study First Post Date: 2022-07-18
Study First Post Date Type: ACTUAL
Results First Submit Date: 2025-02-27
Results First Submit QC Date: None
Results First Post Date: 2025-04-27
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-04-10
Last Update Post Date: 2025-04-27
Last Update Post Date Type: ACTUAL